Transgene Sa Stock Shares Owned By Insiders
TNG Stock | EUR 0.71 0.02 2.74% |
Transgene SA fundamentals help investors to digest information that contributes to Transgene's financial success or failures. It also enables traders to predict the movement of Transgene Stock. The fundamental analysis module provides a way to measure Transgene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Transgene stock.
Transgene |
Transgene SA Company Shares Owned By Insiders Analysis
Transgene's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition |
Based on the latest financial disclosure, 0.0% of Transgene SA are shares owned by insiders. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The shares owned by insiders for all France stocks is 100.0% higher than that of the company.
Transgene Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Transgene's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Transgene could also be used in its relative valuation, which is a method of valuing Transgene by comparing valuation metrics of similar companies.Transgene is currently under evaluation in shares owned by insiders category among its peers.
Transgene Fundamentals
Return On Equity | -0.36 | |||
Return On Asset | -0.16 | |||
Profit Margin | (1.27) % | |||
Operating Margin | (1.39) % | |||
Current Valuation | 144.73 M | |||
Shares Outstanding | 100.2 M | |||
Shares Owned By Institutions | 1.70 % | |||
Price To Earning | 18.08 X | |||
Price To Book | 3.39 X | |||
Price To Sales | 10.07 X | |||
Revenue | 9.99 M | |||
Gross Profit | (15.87 M) | |||
EBITDA | (16.55 M) | |||
Net Income | (19.54 M) | |||
Cash And Equivalents | 16.9 M | |||
Cash Per Share | 0.27 X | |||
Debt To Equity | 162.30 % | |||
Current Ratio | 1.52 X | |||
Book Value Per Share | 0.55 X | |||
Cash Flow From Operations | (31.94 M) | |||
Earnings Per Share | (0.23) X | |||
Target Price | 4.3 | |||
Number Of Employees | 143 | |||
Beta | 0.79 | |||
Market Capitalization | 205.42 M | |||
Total Asset | 101.84 M | |||
Retained Earnings | (538 M) | |||
Working Capital | 24 M | |||
Current Asset | 51 M | |||
Current Liabilities | 27 M | |||
Z Score | -7.0 | |||
Net Asset | 101.84 M |
About Transgene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Transgene SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Transgene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Transgene SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Transgene Stock
Transgene financial ratios help investors to determine whether Transgene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.